What is the official website of Genentech Medical ?

The official website of Genentech Medical is https://www.genentech-medinfo.com/.

What is Genentech Medical's cybersecurity risk score?

Genentech Medical has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Genentech Medical experienced?

According to Rankiteo, Genentech Medical currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Genentech Medical been affected by any supply chain cyber incidents ?

According to Rankiteo, Genentech Medical has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Genentech Medical have SOC 2 Type 1 certification ?

According to Rankiteo, Genentech Medical is not certified under SOC 2 Type 1.

Does Genentech Medical have SOC 2 Type 2 certification ?

According to Rankiteo, Genentech Medical does not hold a SOC 2 Type 2 certification.

Does Genentech Medical comply with GDPR ?

According to Rankiteo, Genentech Medical is not listed as GDPR compliant.

Does Genentech Medical have PCI DSS certification ?

According to Rankiteo, Genentech Medical does not currently maintain PCI DSS compliance.

Does Genentech Medical comply with HIPAA ?

According to Rankiteo, Genentech Medical is not compliant with HIPAA regulations.

Does Genentech Medical have ISO 27001 certification ?

According to Rankiteo,Genentech Medical is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Genentech Medical operate in ?

Genentech Medical operates primarily in the Biotechnology Research industry.

How many employees does Genentech Medical have ?

Genentech Medical employs approximately None employees people worldwide.

Does Genentech Medical own any subsidiaries ?

Genentech Medical presently has no subsidiaries across any sectors.

How many LinkedIn followers does Genentech Medical have ?

Genentech Medical's official LinkedIn profile has approximately 3,436 followers.

What is the NAICS classification code for Genentech Medical ?

Genentech Medical is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Genentech Medical have a Crunchbase profile ?

No, Genentech Medical does not have a profile on Crunchbase.

Does Genentech Medical have a LinkedIn profile ?

Yes, Genentech Medical maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/genentech-medical.

How many cybersecurity incidents has Genentech Medical experienced ?

As of July 22, 2026, Rankiteo reports that Genentech Medical has not experienced any cybersecurity incidents.

How many peer or competitor companies does Genentech Medical have ?

Genentech Medical has an estimated 4,731 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Genentech Medical

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Genentech Medical Vendor Cyber Rating & Cyber Score

genentech-medinfo.com

Add Your Compliance Badge

The official Genentech Medical LinkedIn page for sharing the latest scientific, medical, and clinical trial information with US healthcare professionals. • By interacting with this LinkedIn page, you confirm that you are a US healthcare professional. • There are regulations that govern our LinkedIn page. We reserve the right to engage with posts that follow our community guidelines (https://bit.ly/4aqwv2h). Not all posts will receive responses. Responses will be provided during business hours M-F, 5am to 5pm PT. • This page provides a platform for Genentech Medical Affairs to share scientific information, disease education, and clinical trial updates. We welcome your comments. Please stay on topic and refrain from using inappropriate

Genentech Medical A.I CyberSecurity Scoring

Scoring History

Genentech Medical

Genentech Medical CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Genentech Medical Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Genentech Medical

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech Medical in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Genentech Medical in 2026.

Incident Types Genentech Medical vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech Medical in 2026.

Incident History - Genentech Medical (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Genentech Medical Subsidiaries

Genentech Medical

Biotechnology Research

Website: https://www.genentech-medinfo.com/

Company Size: 10,001+ employees

RocheBiotechnology Research

Roche SwedenTillverkning av läkemedel

Roche Middle EastBiotechnology Research

Roche MéxicoPharmaceutical Manufacturing

Ventana Medical SystemsBiotechnology Research

GenMark DiagnosticsMedical Equipment Manufacturing

Roche Diabetes CareMedical Equipment Manufacturing

Roche Diagnostics Asia PacificBiotechnology Research

Carmot Therapeutics, Inc.Biotechnology Research

Roche AustraliaBiotechnology Research

Roche Diagnostics BelgiumBiotechnology Research

Roche Malaysia Penyelidikan Bioteknologi

Roche Sequencing USABiotechnology Research

Roche Diagnostics NederlandHospitals and Health Care

LabLeadersHospitals and Health Care

Roche HungaryBiotechnology Research

中外製薬 / Chugai Pharmaceutical Co., Ltd.Pharmaceutical Manufacturing

Roche VietnamBiotechnology Research

Roche Diagnostics AustraliaBiotechnology Research

Roche Diagnostics DanmarkMedical Equipment Manufacturing

Roche IndonesiaBioteknologi

Roche Diagnostics SwedenHospitals and Health Care

Roche Tunisiaتصنيع المستحضرات الصيدلانية

Roche IsraelPharmaceutical Manufacturing

Roche Hong Kong 羅氏香港Biotechnology Research

Roche DanmarkForskning inden for bioteknologi

Roche in Belgium & LuxembourgBiotechnology Research

Roche Diagnostics FranceFabrication d’équipements médicaux

Roche DeutschlandBiotechnologieforschung

Roche Costa RicaInvestigación biotecnológica

Roche BangladeshPharmaceutical Manufacturing

Roche PerúFabricación de productos farmacéuticos

Roche Diagnostics PakistanBiotechnology Research

Roche CanadaBiotechnology

Roche FranceRecherche en biotechnologie

Roche in AustriaArzneimittelherstellung

Fondation RocheOrganisations à but non lucratif

Roche CustomBiotech - North AmericaBiotechnology Research

Roche Česká republikaBiotechnologie

Roche LATAMPesquisa biotecnológica

Roche ChileFabricación de productos farmacéuticos

Roche Diagnostics USABiotechnology Research

Roche EcuadorFabricación de productos farmacéuticos

Roche PolskaProdukcja wyrobów farmaceutycznych

Roche i NorgeSykehus og helsetjenester

Roche ArgentinaFabricación de productos farmacéuticos

Healthcare TransformersBiotechnology Research

Roche Diabetes Care FranceFabrication d’équipements médicaux

Roche AfricaBiotechnology Research

Roche UruguayFabricación de productos farmacéuticos

GenentechBiotechnology Research

Loading…

Genentech Medical Similar Companies

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Loading…

NEWS

Genentech Medical CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 16, 2026 02:50 PM

Genentech CEO says aiming for tolerable, affordable obesity drugs

The CEO of Roche's Genentech unit, Ashley Magargee, said on Monday the company is striving to build a portfolio of obesity medicines that...

Read Article

February 07, 2026 08:00 AM

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority...

Read Article

December 16, 2025 08:00 AM

Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need

PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine...

Read Article

October 22, 2025 07:00 AM

Ventus and Genentech partner for small-molecule medicine discovery

Ventus has entered a multi-year partnership with Roche's Genentech for the discovery and optimisation of new small-molecule medicines.

Read Article

August 11, 2025 07:00 AM

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...

Read Article

May 24, 2024 07:00 AM

Cencora data breach exposes patient data at top pharma firms

The Cencora breach affected some of the most prominent Big Pharma firms, including Novartis, Bayer, AbbVie, Regeneron, Genentech and Incyte.

Read Article

November 23, 2021 08:00 AM

Flywheel Partners with Roche and Genentech to Accelerate Development of Personalized Healthcare Solutions

November 23, 2021 — Flywheel, a cloud-scale informatics platform for biomedical research and collaboration, announced the successful...

Read Article

November 23, 2021 08:00 AM

Flywheel working with Roche and Genentech to sift through medical imaging data

Flywheel has announced that Roche and Genentech are using its cloud-scale informatics platform to process medical imaging data.

Read Article

October 17, 2019 07:00 AM

CSL: Former exec stole 'thousands' of secret files before joining rival Pharming

CSL sued former exec Joseph Chiao for stealing key info on his way to Pharming, which markets Ruconest to treat angioedema attacks in patients with HAE.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-63261

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-72/388575

CVE-2026-63260

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-71/388574

CVE-2026-63259

SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-9-4-4-security-update-esa-2026-70/388573

CVE-2026-63145

SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-69/388572

CVE-2026-63144

SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/elasticsearch-8-19-19-9-3-8-9-4-4-security-update-esa-2026-68/388571

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…